OTCMKTS:GRRMF Gerresheimer Earnings Date & Estimates $37.47 0.00 (0.00%) As of 10/30/2026 Gerresheimer is estimated to report earnings on Wednesday, November 4, 2026, before market opens. Research:ProfileForecast Upcoming Earnings Announcement Announcement DateNovember 4, 2026TimeBefore Market Opens Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from GerresheimerGerresheimer is expected to post earnings of $0.3166 per share on revenue of $671.32 million.Consensus EstimatesConsensus EPS$0.3166Expected Revenue$671.32 millionPrepare for the Earnings CallCompany Profile Gerresheimer Earnings FAQ When does Gerresheimer report earnings? Gerresheimer (OTCMKTS:GRRMF) is estimated to report earnings on Wednesday, November 4, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Gerresheimer? Analysts expect Gerresheimer to post earnings of $0.3166 per share for the quarter. How much revenue is Gerresheimer expected to report? The consensus revenue estimate for Gerresheimer is $671.32 million for the quarter. Gerresheimer Earnings HeadlinesGerresheimer reports lower half-year core profitSeptember 30, 2026 | reuters.comDeutsche Bank Sticks to Its Hold Rating for Gerresheimer (0NTI)August 18, 2026 | theglobeandmail.comFederal Reserve’s Disturbing Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.November 1 at 1:00 AM | Weiss Ratings (Ad)Gerresheimer (0NTI) Gets a Hold from Deutsche BankAugust 10, 2026 | theglobeandmail.comGermany's Gerresheimer to sell two units to Apax for $1.71 billion including debtJuly 28, 2026 | reuters.comGerresheimer AG (GRRMF) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...June 30, 2026 | finance.yahoo.comSee More Gerresheimer Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Gerresheimer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gerresheimer and other key companies, straight to your email. Email Address About GerresheimerGerresheimer (OTCMKTS:GRRMF) is a Germany-based manufacturer of pharmaceutical and healthcare packaging and drug-delivery systems. The company develops and produces primary packaging and components used to protect, store and administer medicines, serving pharmaceutical, biotechnology and healthcare customers worldwide. Its product portfolio includes glass and plastic containers such as vials, ampoules, bottles, cartridges and syringes, as well as delivery systems including inhalers, injection pens, autoinjectors and other medical devices. Gerresheimer also provides development, engineering and manufacturing services for customized drug-delivery solutions. Founded in 1864 and headquartered in Düsseldorf, Germany, Gerresheimer operates production and development facilities across Europe, North America, South America and Asia. The company supplies customers in global pharmaceutical and healthcare markets, with additional products and services for the cosmetics industry.View Gerresheimer ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Exxon's Refining Profits Soared—Did Chevron Get the Same Windfall?LyondellBasell's Dividend Looks Safer, But a New Risk Could Change ThatEli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?Silicon Shock: Intel's 25% Valuation ResetMarketBeat Week in Review – 10/26 - 10/30DoorDash's $17 Billion Bet on Instacart Faces a Long Regulatory Road AheadAmazon's Record Margins Couldn't Stop the Sell-Off—Here's Why Upcoming Earnings Marriott International (11/2/2026)Diamondback Energy (11/2/2026)Williams Companies (11/2/2026)Vertex Pharmaceuticals (11/2/2026)Realty Income (11/2/2026)Apple (11/2/2026)Palantir Technologies (11/2/2026)Entergy (11/2/2026)Booking (11/3/2026)Ferrari (11/3/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
